Report image for AI Clinical Trial Digital Workforce Market Size, Trend & Opportunity Analysis Report, By Application (Patient Recruitment & Retention, Trial Design & Protocol Optimization, Data Collection & Management, Regulatory Submission & Compliance), By Offering Type (Software Platforms, Services), By Therapeutic Area (Oncology, Central Nervous System & Neurology, Cardiovascular & Metabolic Disorders, Infectious Diseases, Rare Diseases), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Medical Centers & Investigator Sites), By Technology Deployment (Cloud-Based Solutions, On-Premises/Hybrid Architectures), Global and Regional Forecast 2026-2035

Global AI Clinical Trial Digital Workforce Market Size, Opportunity Analysis and Forecast, 2026-2035

The Global AI Clinical Trial Digital Workforce Market was valued at USD 1.52 billion in 2025, and is projected to reach USD 4.94 billion by 2035, growing at a CAGR of 12.50% from 2026 to 2035.

Code: LSDB1600Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Clinical Knowledge Graph Platform Market Size, Trend & Opportunity Analysis Report, By Platform Type (Enterprise Clinical Knowledge Graph Platforms, Biomedical Knowledge Graph Platforms, Semantic Data Integration Platforms, AI Clinical Reasoning Platforms, Research Knowledge Graph Platforms, Federated Knowledge Graph Platforms), By Deployment (Cloud-Based, On-Premises, Hybrid), By Technology (Knowledge Graphs, Graph Databases, Semantic Web Technologies, RDF & OWL Frameworks, Natural Language Processing, Machine Learning, Large Language Models, Graph Neural Networks), By Data Source (Electronic Health Records, Clinical Trial Data, Genomic Data, Medical Imaging, Laboratory Information Systems, Biomedical Literature, Real-World Evidence, Drug & Molecular Databases), By Application (Clinical Decision Support, Precision Medicine, Drug Discovery, Clinical Research, Disease Pathway Analysis, Population Health Management, Medical Knowledge Management, Pharmacovigilance, Clinical Trial Optimisation, Healthcare Analytics), By End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations, Government Healthcare Agencies), Global and Regional Forecast 2026-2035

Global Clinical Knowledge Graph Platform Market Size Opportunity Analysis Strategic Forecast 2026-2035

The Global Clinical Knowledge Graph Platform Market was valued at USD 2.05 billion in 2025, and is projected to reach USD 27.55 billion by 2035, growing at a CAGR of 29.67% from 2026 to 2035.

Code: LSHI1604Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Cell Therapy Manufacturing Automation Market Size, Trend & Opportunity Analysis Report, By Therapy Type (Allogenic Cell Therapy, Autologous Cell Therapy), By Technology Type (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, 3D Technology), By Source (IPSC, Bone Marrow, Umbilical Cord, Adipose Tissues, Neural Stem), By Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), Global and Regional Forecast 2026-2035

Global Cell Therapy Manufacturing Automation Market Size, Opportunity Analysis and Forecast, 2026-2035

The Global Cell Therapy Manufacturing Automation Market was valued at USD 5.55 billion in 2025, and is projected to reach USD 21.02 billion by 2035, growing at a CAGR of 14.24% from 2026 to 2035.

Code: LSTH1605Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Digital Pathology AI Foundation Model Market Size, Trend & Opportunity Analysis Report, By Model Type (Vision Foundation Models, Pathology Language-Image Models, Multimodal Foundation Models, Self-Supervised Foundation Models, Generative AI Foundation Models, Transformer-Based Pathology Models), By Deployment (Cloud-Based, On-Premises, Hybrid), By Data Modality (Whole-Slide Images, Histopathology Images, Pathology Reports, Genomic Data, Proteomic Data, Clinical Data, Radiology Images, Multi-Omics Data), By Application (Cancer Diagnosis, Tumour Classification, Biomarker Detection, Companion Diagnostics, Prognosis Prediction, Rare Disease Diagnosis, Drug Discovery, Clinical Decision Support, Precision Oncology, Research & Biomarker Development), By End User (Hospitals, Diagnostic Laboratories, Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations), Global and Regional Forecast 2026-2035

Global Digital Pathology AI Foundation Model Market Size Opportunity Analysis Strategic Forecast 2026-2035

The Global Digital Pathology AI Foundation Model Market was valued at USD 1.02 billion in 2025, and is projected to reach USD 16.95 billion by 2035, growing at a CAGR of 32.45% from 2026 to 2035.

Code: LSDB1606Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Multimodal Foundation Models for Drug Discovery Market Size, Trend & Opportunity Analysis Report, By Model Type (Molecular Foundation Models, Protein Foundation Models, Multimodal Biomedical Foundation Models, Generative Molecular Models, Diffusion-Based Molecular Models, Graph Foundation Models, Large Language Models for Drug Discovery), By Data Modality (Molecular Structures, Protein Sequences, Protein 3D Structures, Genomic Data, Transcriptomic Data, Biomedical Literature, Medical Imaging, Electronic Health Records, Multi-Omics Data), By Deployment (Cloud-Based, On-Premises, Hybrid), By Application (Target Identification, Hit Discovery, Lead Optimisation, Molecular Property Prediction, Drug Repurposing, Toxicity Prediction, ADMET Prediction, Biomarker Discovery, Clinical Candidate Selection, Precision Medicine), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organisations, Academic Research Institutes, AI Drug Discovery Start-ups, Government Research Organisations), Global and Regional Forecast 2026-2035

Global Multimodal Foundation Models for Drug Discovery Market Size Opportunity Analysis Strategic Forecast 2026-2035

The Global Multimodal Foundation Models for Drug Discovery Market was valued at USD 1.58 billion in 2025, and is projected to reach USD 26.06 billion by 2035, growing at a CAGR of 32.35% from 2026 to 2035.

Code: LSDB1608Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Autoimmune Encephalitis Treatment & Diagnostics Market Size, Trend & Opportunity Analysis Report, By Treatment Type (First-line Immunotherapy, B-cell Targeted Therapy, Immunosuppressant, Emerging Biologics & FcRn/Cytokine Therapies, Others), By Diagnostic Method (Autoantibody Testing, MRI & Neuroimaging, EEG, CSF Analysis & Biomarkers, Others), By Disease Type (Anti-NMDA Receptor Encephalitis, LGI1 Encephalitis, CASPR2 Encephalitis, Paraneoplastic Autoimmune Encephalitis, Others), By End User (Hospitals, Neurology Specialty Centers, Academic & Research Institutes, Diagnostic Laboratories, Others), Global and Regional Forecast 2026-2035

Global Autoimmune Encephalitis Treatment & Diagnostics Market Size, Opportunity Analysis and Forecast, 2026-2035

The Global Autoimmune Encephalitis Treatment & Diagnostics Market was valued at USD 1.82 billion in 2025, and is projected to reach USD 4.16 billion by 2035, growing at a CAGR of 8.61% from 2026 to 2035.

Code: LSTH1610Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Dental Ceramic Biomaterials Market Size, Trend & Opportunity Analysis Report, By Biomaterials Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Others), By Application (Implantology, Orthodontics, Prosthodontics, Others), By End User (Hospitals, Dental Clinics, Others), Global and Regional Forecast 2026-2035

Global Dental Ceramic Biomaterials Market Size, Opportunity Analysis and Forecast, 2026-2035

The Global Dental Ceramic Biomaterials Market was valued at USD 3.47 billion in 2025, and is projected to reach USD 9.09 billion by 2035, growing at a CAGR of 10.10% from 2026 to 2035.

Code: LSMD1611Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Dental Intraoral Cameras Market Size, Trend & Opportunity Analysis Report, By Type (Wired, Wireless), By Technology (Complementary Metal-Oxide-Semiconductor, Charge-Coupled Device), By End-user (Solo Practices, DSO/Group Practices, Others), Global and Regional Forecast 2026-2035

Global Dental Intraoral Cameras Market Size, Opportunity Analysis and Forecast, 2026-2035

The Global Dental Intraoral Cameras Market was valued at USD 340.88 million in 2025, and is projected to reach USD 860.34 million by 2035, growing at a CAGR of 9.70% from 2026 to 2035

Code: LSMD1614Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Immunosenescence Market Size, Trend & Opportunity Analysis Report, By Product Type (Therapeutics, Diagnostics, Biomarker Assays, Software & AI Platforms, Research Reagents, Clinical Services), By Therapy Type (Senolytic Therapies, Senomorphic Therapies, Cytokine Modulators, Immune Checkpoint Modulators, Stem Cell-Based Therapies, Gene Therapies, Peptide Therapeutics, Small Molecule Therapeutics), By Mechanism of Action (T-Cell Rejuvenation, B-Cell Function Enhancement, Innate Immune Modulation, Thymic Regeneration, Inflammaging Reduction, Cellular Senescence Targeting, Epigenetic Reprogramming, Metabolic Immune Regulation), By Application (Healthy Ageing, Vaccine Response Enhancement, Infectious Disease Prevention, Oncology, Autoimmune Disorders, Chronic Inflammatory Diseases, Organ Transplantation, Precision Medicine), By End User (Pharmaceutical Companies, Biotechnology Companies, Hospitals, Academic & Research Institutes, Contract Research Organisations, Government Research Organisations), Global and Regional Forecast 2026-2035

Global Immunosenescence Market Size Opportunity Analysis Strategic Forecast 2026-2035

The Global Immunosenescence Market was valued at USD 3.85 billion in 2025, and is projected to reach USD 26.77 billion by 2035, growing at a CAGR of 21.4% from 2026 to 2035.

Code: LSTH1615Pages: 293
Available In:
Format 1Format 2Format 3
Report image for Epigenomics Market Size, Trend & Opportunity Analysis Report, By Product Type (Instruments: Next-Generation Sequencing Systems, Long-Read Sequencing Platforms, Single-Cell Epigenomics Systems, Chromatin Analysis Instruments; Consumables: Library Preparation Kits, DNA Methylation Assays, Antibodies, Reagents, Sequencing Consumables; Software: Bioinformatics Platforms, AI-Based Epigenomics Analytics, Multi-Omics Integration Software, Cloud-Based Data Platforms; Services: Epigenomic Sequencing Services, Biomarker Discovery Services, Bioinformatics Services, Contract Research Services), By Technology (DNA Methylation Analysis, Histone Modification Analysis, ATAC-Seq, ChIP-Seq, Whole Genome Bisulphite Sequencing, Single-Cell Epigenomics, Spatial Epigenomics, Epigenome Editing, Multi-Omics Integration), By Application (Oncology, Precision Medicine, Neurological Disorders, Cardiovascular Diseases, Autoimmune Diseases, Rare Diseases, Drug Discovery, Developmental Biology, Regenerative Medicine, Ageing Research), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Hospitals, Diagnostic Laboratories, Contract Research Organisations), Global and Regional Forecast 2026-2035

Global Epigenomics Market Size Opportunity Analysis Strategic Forecast 2026-2035

The Global Epigenomics Market was valued at USD 18.60 billion in 2025, and is projected to reach USD 54.01 billion by 2035, growing at a CAGR of 11.25% from 2026 to 2035.

Code: LSDB1618Pages: 293
Available In:
Format 1Format 2Format 3
List per Page:
1of 33